IBA sells part of dosimetry unit

By AuntMinnieEurope.com staff writers

December 17, 2019 -- Proton therapy developer Ion Beam Applications (IBA) has sold its RadioMed unit to IZI Medical Products for an estimated price of 12.6 million euros to 16.6 million euros.

RadioMed, which IBA acquired in 2003, makes Visicoil, an implantable fiducial marker for soft-tissue tumor localization designed to enhance the accuracy of radiation therapy planning and delivery. IZI develops, manufactures, and provides medical consumable devices for interventional radiology and oncology, radiation therapy, neuro-spine, and image-guided surgery procedures.

IBA will retain ownership of the rest of its dosimetry products and business.


Copyright © 2019 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: